Olivier Andréoletti Selected Research

Endopeptidase K (Proteinase K)

6/2021	Cerebrospinal Fluid and Plasma Small Extracellular Vesicles and miRNAs as Biomarkers for Prion Diseases.
1/2020	Prion infection, transmission, and cytopathology modeled in a low-biohazard human cell line.
4/2008	Rapid typing of transmissible spongiform encephalopathy strains with differential ELISA.
3/2008	Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
3/2008	Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Andréoletti Research Topics

Disease

38	Scrapie 01/2022 - 08/2002
32	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022 - 10/2002
16	Infections 06/2021 - 03/2008
13	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2022 - 02/2005
11	Bovine Spongiform Encephalopathy (Mad Cow Disease) 04/2021 - 04/2006
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2002
7	Sporadic Creutzfeldt-Jakob Disease 01/2021 - 03/2008
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2016
3	Acquired CJD 11/2017 - 12/2009
2	Neuroblastoma 12/2015 - 02/2005
1	Granuloma 10/2019
1	Disease Progression 01/2019
1	Fatal Familial Insomnia 01/2018
1	Dementia (Dementias) 01/2018
1	Neoplasms (Cancer) 11/2017
1	Inflammation (Inflammations) 01/2017
1	Asymptomatic Diseases 01/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2013
1	Brain Diseases (Brain Disorder) 12/2009
1	Mastitis 12/2008

Drug/Important Bio-Agent (IBA)

49	PrionsIBA 01/2022 - 10/2002
25	Prion ProteinsIBA 01/2020 - 08/2002
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2002
5	Endopeptidase K (Proteinase K)IBA 06/2021 - 03/2008
4	Codon (Codons)IBA 07/2017 - 10/2002
3	Peptide Hydrolases (Proteases)FDA Link 11/2019 - 07/2017
3	Protein Isoforms (Isoforms)IBA 03/2019 - 10/2002
3	Amyloid (Amyloid Fibrils)IBA 05/2018 - 10/2002
3	PrPSc ProteinsIBA 01/2014 - 03/2008
2	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 06/2021 - 11/2010
2	Monoclonal AntibodiesIBA 07/2017 - 06/2010
2	Biological ProductsIBA 07/2015 - 11/2010
2	Valine (L-Valine)FDA Link 03/2008 - 03/2008
2	Methionine (L-Methionine)FDA Link 03/2008 - 03/2008
1	Protein AggregatesIBA 01/2022
1	Detergents (Detergent)IBA 04/2021
1	keratinaseIBA 04/2021
1	Growth Hormone (Somatotropin)IBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	Coloring Agents (Dyes)IBA 10/2019
1	LigandsIBA 03/2019
1	Eph Family Receptors (Eph Receptors)IBA 03/2019
1	EphrinsIBA 03/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2018
1	Lim KinasesIBA 05/2018
1	Phosphotransferases (Kinase)IBA 05/2018
1	Food Loss and WasteIBA 02/2018
1	Cell ExtractsIBA 02/2018
1	Caseins (Casein)FDA Link 02/2018
1	ChitinasesIBA 11/2017
1	Glycoproteins (Glycoprotein)IBA 11/2017
1	Messenger RNA (mRNA)IBA 10/2017
1	Reelin ProteinIBA 10/2017
1	Lysine (L-Lysine)FDA Link 07/2017
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2017
1	CalciumIBA 01/2017
1	CalpainIBA 01/2017
1	CathepsinsIBA 01/2017
1	PresenilinsIBA 01/2017
1	TEMPOIBA 01/2016
1	CytokinesIBA 01/2014
1	Amino Acids FDA Link 12/2013
1	AntibodiesIBA 06/2010
1	Quinacrine (Mepacrine)IBA 02/2005
1	AntigensIBA 10/2002
1	Glycoside Hydrolases (Endoglycosidases)IBA 08/2002

Therapy/Procedure

4	Blood Transfusion (Blood Transfusions) 01/2021 - 02/2012
1	Euthanasia (Mercy Killing) 01/2018
1	Intravenous Administration 01/2016
1	Immunotherapy 06/2010